The Comparison of Amlodipine vs Enalapril to Limit Occurrences of Thrombosis (CAMELOT) trial studied the effects of a calcium-channel blocker (amlodipine) and an angiotensin-converting-enzyme ...
In this case, only amlodipine besylate was subject to regulatory review. The decision allows Pfizer to continue its infringement action in the district court.
Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...